PR Newswire
PR Newswire is the industry’s leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.
POMDOCTOR LIMITED Advances Healthcare Data Asset Strategy to Strengthen AI-Powered Chronic Disease Management Capabilities
GUANGZHOU, China, July 15, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on...
Read more
Leading the Network 2030: WBBA Officially Launches AI-Net, a Globally Authoritative Data Communications Certification
BANGKOK, July 15, 2026 /PRNewswire/ -- At the Asia-Pacific Broadband Development Summit (BDS), the World Broadband Association (WBBA) officially launched...
Read moreHIGHWAY HOLDINGS REPORTS FISCAL FOURTH QUARTER AND FULL YEAR 2026 RESULTS
HONG KONG, July 15, 2026 /PRNewswire/ -- Highway Holdings Limited (Nasdaq: HIHO, the "Company" or "Highway Holdings") today reported results for...
Read moreStable Launches StablePay: Instant, Zero-Fee Global Payments App Built on Stablecoin Rails
Payments that move at the speed of the internet - send digital dollars anywhere in seconds, with no fees and...
Read moreInitiative on Joint Promotion of World Cultural Heritage Launched in Chongzuo, China
CHONGZUO, China, July 15, 2026 /PRNewswire/ -- This is a report from china-asean-media.com. The 2026 ASEAN-China Cultural Exchange Cooperation Forum was...
Read more
Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Asthma
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 15, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed...
Read more
Kelun-Biotech and Harbour BioMed Announce NMPA Approval of IND Application for SKB575/HBM7575 for the Treatment of Asthma
CHENGDU, China, July 15, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) and Harbour BioMed...
Read more
Ascletis Selects for Clinical Development a Fixed-Dose Combination of First-in-Class Oral Small Molecule GIPR Agonist, ASC48, and Oral Small Molecule GLP-1R Agonist, ASC30
- ASC48 is a potentially first-in-class oral small molecule GIPR agonist. - ASC48 demonstrated an EC50 of 1 pM in...
Read more
CLASSYS Appoints Former Samsung Electronics Vice President Jun-oh Yoon as CEO to Lead Its Next Stage of Global Growth
Former Samsung Group and Samsung Electronics executive who led corporate growth strategy and major global M&A initiatives across the Corporate...
Read more
Solos Unveils Next-Generation AirGo™ A6 and New Privacy Kit, Launches AirGo™ V2 Worldwide at Third Annual AI Smartglasses Symposium in Hong Kong
HONG KONG, July 15, 2026 /PRNewswire/ -- Solos®, a leading innovator in smartglasses and wearable AI, marks a landmark moment at...
Read more
Recent News
Stay ahead with the latest insights on Hong Kong’s economy, finance, and investments. From market trends to policy updates, we bring you in-depth analysis and expert opinions.
📩 Subscribe to our newsletter for exclusive updates.
📍 Follow us on social media for real-time news.
📧 Contact us: info@hongkong-invest.com